{"id":"W3064741431","doi":"10.1158/1078-0432.ccr-20-0037","title":"Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; Canadian Association of Thoracic Surgeons; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; FUJIFILM Pharmaceuticals U.S.A.; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; Medicine; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Antibody; Dosimetry; Monoclonal antibody; Cancer; Toxicity; Internal medicine; Cancer research; Pathology; Oncology; Nuclear medicine; Phases of clinical research; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106007,0.0001534513,0.00064655,0.00006428514,0.00007490351,0.00001456904,0.0002894852,0.0001069074,0.0007523705],"category_scores_gemma":[0.0003124762,0.0001207027,0.00009312195,0.001069538,0.0005005783,0.00004948663,0.0000686093,0.001445701,0.00002095313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007572333,"about_ca_system_score_gemma":0.0005153444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001615928,"about_ca_topic_score_gemma":0.000009517966,"domain_scores_codex":[0.9972599,0.00024832,0.0008136731,0.0005469228,0.0006980562,0.0004331688],"domain_scores_gemma":[0.9983093,0.0004585379,0.00009582376,0.0004081572,0.0002650128,0.0004631268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03952724,0.03030873,0.342189,0.0006354156,0.0007253675,0.0007478285,0.002637871,0.0002138276,0.5507039,0.00007547643,0.002547789,0.02968759],"study_design_scores_gemma":[0.2000341,0.06096504,0.3540182,0.001154649,0.0003674859,0.00005611177,0.007407143,0.01898729,0.3153208,0.0001946521,0.04014686,0.001347694],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924664,0.0007214852,0.00003379354,0.004984769,0.0000220914,0.001166064,0.00002357027,0.00003246257,0.0005494002],"genre_scores_gemma":[0.9979709,0.0005646762,0.0001280767,0.0004780276,0.0004172485,0.0002363229,0.00002025378,0.00003252185,0.0001519851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2353832,"threshold_uncertainty_score":0.8237929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.352634513895786,"score_gpt":0.6222635232220715,"score_spread":0.2696290093262854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}